Clinical Trials List
2022-09-01 - 2025-12-31
Phase I
Recruiting7
Terminated1
-
Trial Applicant
AbbVie
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Chih-Yen Tu 未分科
- Chia-Hsiang Li 未分科
- Yu-Chao Lin 未分科
- 陳鴻仁 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chia-I Shen 未分科
- Hsu-ching Huang 未分科
- Heng-Sheng Chao 未分科
- Yung-Hung Luo 未分科
- YEN-HAN TSENG 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 黃文冠 未分科
- Jen-Shi Chen 未分科
- 曾振輝 未分科
- 吳教恩 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chong-Jen Yu 無
- James Chih-Hsin Yang 無
- 蔡子修 無
- CHAO-CHI HO CHAO-CHI HO 無
- YEN-TING LIN 無
- 許嘉林 無
- 廖斌志 無
- Jih-Hsiang Lee 無
- 徐偉勛 無
- 廖唯昱 無
- 吳尚俊 無
- JIN-YUAN SHIH 無
- 楊景堯 無
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
36 participants
-
Global
500 participants